Company Filing History:
Years Active: 2020
Title: Dmitry Trubetskoy: Innovator in Lentiviral Vector Technology
Introduction
Dmitry Trubetskoy is a notable inventor based in Arcueil, France. He has made significant contributions to the field of biotechnology, particularly in the development of lentiviral vectors for therapeutic applications. His work focuses on innovative methods to enhance immune responses and treat various cancers.
Latest Patents
Dmitry Trubetskoy holds a patent for "Lentiviral vectors for regulated expression of a chimeric antigen receptor molecule." This invention relates to the regulated expression of a chimeric antigen receptor (CAR) within a lentiviral vector. The CAR includes a hook-binding domain that interacts with a hook, preferably encoded by the same lentiviral vector, which prevents proper processing and release of the CAR to the cell membrane. The invention encompasses vectors, methods of making the vectors, and methods of using them, including medicinal uses. The vectors can be administered to humans to induce immune responses and treat cancers and tumors. He has 1 patent to his name.
Career Highlights
Throughout his career, Dmitry has worked with prominent organizations in the biotechnology sector. Notably, he has been associated with Theravectys and Institut Curie, where he has contributed to groundbreaking research and development in the field.
Collaborations
Dmitry Trubetskoy has collaborated with several professionals in his field, including Sophie Agaugue and Lorenzo Tibaldi. These collaborations have furthered his research and innovation efforts.
Conclusion
Dmitry Trubetskoy is a pioneering inventor whose work in lentiviral vector technology has the potential to revolutionize cancer treatment and immunotherapy. His contributions to the field are invaluable and continue to inspire future innovations.